NCT02462902View on ClinicalTrials.gov

Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension

NACompletedINTERVENTIONAL

Enrollment

308

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions

Cirrhosis With Septic Shock

Interventions

DRUG

5% albumin Infusion

colloid, 5% albumin (250 ml over 15 to 30 minutes).

DRUG

0.9% sodium chloride solution

0.9% sodium chloride solution (total of 30ml/kg over 15 to 30 minutes)

Trial Locations (1)

110070

Institute of Liver and Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT02462902 - Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension | Biotech Hunter | Biotech Hunter